Nihon Kohden (OTCMKTS:NHNKY) Sees Large Volume Increase – Should You Buy?

Posted by on Jun 17th, 2026

Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 187,851 shares traded hands during trading, an increase of 615% from the previous session’s volume of 26,287 shares.The stock last traded at $8.58 and had previously closed at $8.4425.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy”.

Read Our Latest Stock Report on NHNKY

Nihon Kohden Stock Performance

The firm has a market cap of $1.47 billion, a PE ratio of 14.54 and a beta of 0.39. The stock has a fifty day moving average price of $9.22 and a 200-day moving average price of $10.16.

Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. The firm had revenue of $453.10 million during the quarter, compared to analysts’ expectations of $414.40 million. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%. As a group, equities analysts predict that Nihon Kohden Corporation will post 0.61 earnings per share for the current fiscal year.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

Featured Articles

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.